These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 2556230
41. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes. Goldman DW, Enkel H, Gifford LA, Chenoweth DE, Rosenbaum JT. J Immunol; 1986 Sep 15; 137(6):1971-6. PubMed ID: 3018083 [Abstract] [Full Text] [Related]
42. Metabolism of leukotriene B4 by activated human polymorphonuclear granulocytes. Brom J, Schönfeld W, König W. Immunology; 1988 Jul 15; 64(3):509-18. PubMed ID: 2842254 [Abstract] [Full Text] [Related]
43. Comparison of the generation in vitro of chemotactically active LTB4 and its omega-metabolites by human neutrophils and lymphocytes/monocytes. Rosenbach T, Czarnetzki BM. Clin Exp Immunol; 1987 Jul 15; 69(1):221-8. PubMed ID: 2820638 [Abstract] [Full Text] [Related]
44. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine. Harvath L, McCall CE, Bass DA, McPhail LC. J Immunol; 1987 Nov 01; 139(9):3055-61. PubMed ID: 2822802 [Abstract] [Full Text] [Related]
45. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release. Conti P, Barbacane RC, Reale M, Panara MR, Placido FC, Mier JW, Castracane JM, Dempsey RA. Biotechnol Ther; 1993 Nov 01; 4(3-4):239-52. PubMed ID: 8292972 [Abstract] [Full Text] [Related]
47. Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents. O'Flaherty JT, Wykle RL, Lees CJ, Shewmake T, McCall CE, Thomas MJ. Am J Pathol; 1981 Dec 01; 105(3):264-9. PubMed ID: 6274199 [Abstract] [Full Text] [Related]
48. Arachidonic acid metabolism in neutrophil granulocytes obtained from synovial fluid in rheumatoid arthritis. Langholz E, Nielsen OH, Ahnfelt-Rønne I, Elmgreen J. Scand J Rheumatol; 1990 Dec 01; 19(6):387-91. PubMed ID: 2175453 [Abstract] [Full Text] [Related]
49. A novel dioxygenation product of arachidonic acid possesses potent chemotactic activity for human polymorphonuclear leukocytes. Shak S, Perez HD, Goldstein IM. J Biol Chem; 1983 Dec 25; 258(24):14948-53. PubMed ID: 6317681 [Abstract] [Full Text] [Related]
50. Changes in the incorporation of free fatty acids upon the stimulation of human polymorphonuclear leukocytes. Phillips WA, Mossmann H, Ferber E. J Leukoc Biol; 1986 Mar 25; 39(3):267-84. PubMed ID: 3080542 [Abstract] [Full Text] [Related]
52. In vivo chemotaxis of bovine neutrophils induced by 5-lipoxygenase metabolites of arachidonic and eicosapentaenoic acid. Heidel JR, Taylor SM, Laegreid WW, Silflow RM, Liggitt HD, Leid RW. Am J Pathol; 1989 Mar 25; 134(3):671-6. PubMed ID: 2538061 [Abstract] [Full Text] [Related]